Source link : https://newshealth.biz/health-news/maker-of-sexual-desire-drug-addyi-gets-fda-warning-letter/
(MedPage Today) — Sprout Pharmaceuticals failed to include drug risk information in a promotional social media post, the FDA said in a warning letter posted on Tuesday. The agency said the company’s CEO Cindy Eckert included a “false or misleading… Source link : https://www.medpagetoday.com/obgyn/generalobgyn/116011 Author : Publish date : 2025-06-11 16:11:00 Copyright for syndicated content […]
The post Maker of Sexual Desire Drug Addyi Gets FDA Warning Letter first appeared on News Health.
—-
Author : News Health
Publish date : 2025-06-11 16:11:00
Copyright for syndicated content belongs to the linked Source.
—-
1 – 2 – 3 – 4 – 5 – 6 – 7 – 8